Answer to Question 1
Correct Answer: 2,5
Rationale 1: This response does not answer the client's question.
Rationale 2: Darbepoetin alfa (Aranesp) is an erythropoiesis-stimulating factor.
Rationale 3: Darbepoetin alfa (Aranesp) does not increase immunity.
Rationale 4: The nurse should explain the medication in terms the client can understand.
Rationale 5: Darbepoetin alfa (Aranesp) stimulates production of red blood cells which carry oxygen. Getting additional oxygen to the tissues helps the client feel better.
Answer to Question 2
Correct Answer: 1,2,4
Rationale 1: The purpose of this therapy is to increase red blood cells which would increase hemoglobin.
Rationale 2: Since the client has more RBCs, more oxygen can be carried to tissues.
Rationale 3: This drug supports RBC production, not platelet production.
Rationale 4: Increase in activity level indicates treatment success.
Rationale 5: This treatment supports red blood cell production, not white blood cell production.
Client position when assessing jugular vein distention.
A, A nurse is adding a medication to an IV line as a piggyback
B, The nurse teaches the postoperative client to use an incentive spirometer to expand the lungs.
The postoperative client supports an incision with a folded pillow when taking a deep breath and cou
Side-effects of major chemotherapy agents
After the chemical exfoliation substance has been applied, wrap the two top sheets around the client ...